ABVC BioPharma, Inc.
ABVC
$0.742
-$0.1725-18.86%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.24M | -11.37M | -12.62M | -10.52M | -12.27M |
| Total Depreciation and Amortization | 29.20K | 29.70K | 23.40K | 28.60K | 27.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 110.10K |
| Total Other Non-Cash Items | 6.77M | 8.38M | 8.33M | 5.45M | 5.50M |
| Change in Net Operating Assets | -352.10K | -362.90K | 1.07M | 803.80K | 2.41M |
| Cash from Operations | -1.80M | -3.33M | -3.21M | -4.24M | -4.22M |
| Capital Expenditure | 0.00 | -21.20K | -21.20K | -21.20K | -21.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 154.20K | 101.60K | -339.00K | -339.00K | -576.40K |
| Cash from Investing | 154.20K | 80.40K | -360.20K | -360.20K | -597.70K |
| Total Debt Issued | 392.20K | -1.43M | -1.46M | 1.46M | 1.35M |
| Total Debt Repaid | -179.10K | 0.00 | 0.00 | -1.00M | -1.00M |
| Issuance of Common Stock | 902.20K | 1.92M | 1.05M | 1.05M | 1.05M |
| Repurchase of Common Stock | -- | -- | -- | -- | -253.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 371.40K | 2.80M | 2.80M | 2.41M | 2.43M |
| Cash from Financing | 1.49M | 3.29M | 2.39M | 3.92M | 3.58M |
| Foreign Exchange rate Adjustments | -197.00K | -42.90K | 50.10K | 2.10K | 387.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -351.10K | 500.00 | -1.13M | -675.00K | -849.20K |
